John Libbey Eurotext

European Journal of Dermatology


Anti-psoriatic properties of paeoniflorin: suppression of the NF-kappaB pathway and Keratin 17 Volume 30, numéro 3, May-June 2020


  • Figure 1
  • Figure 2
  • Figure 3
  • Figure 4
Department of Dermatology, Xijing Hospital, Fourth Military Medical University, 127 West Changle Road, Xi’an 710032, China
* Reprints
a These authors contributed equally.

Background: Psoriasis is a common inflammatory skin disease characterized by hyperproliferation of epidermal keratinocytes, however, there is still no curative therapy for psoriasis. Paeoniflorin (PF), a Chinese herbal medicine, has shown anti-inflammatory effects. Objectives: We aimed to illustrate the effect and associated mechanism of PF on keratinocyte proliferation using the IMQ-induced psoriasis mouse model. Materials and Methods: The anti-psoriatic effect of PF in vivo and in vitro was assessed by western blot, RT-PCR, immunofluorescence, cell counting kit-8 and haematoxylin/eosin staining. Results: In vivo, epidermal thickness, dermal infiltrated lymphocytes and the level of several antimicrobial peptides, pro-inflammatory cytokines, and K17 were significantly reduced in mice with topical application of PF. In vitro, PF inhibited the proliferation of HaCaT cells in a dose-dependent manner, down-regulated K17 expression, and suppressed NF-kappaB activation. Conclusion: Our findings indicate that PF may inhibit the proliferation of keratinocytes by targeting K17, suggesting that PF might be a potential target in the treatment of psoriasis.